Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide
Product Images NDC 53808-1120

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil, Amlodipine And Hydrochlorothiazide (NDC 53808-1120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 20mg / 5mg / 12.5mg (Olmesartan Medoxomil)

Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets with strengths 20 mg, 5 mg, and 12.5 mg respectively. The label indicates a quantity of 30 tablets and prescription-only status. Manufacturer is SUN. The packaging is by DOH Central Pharmacy, Tallahassee, FL 32304. The label includes lot number 010-25-2018-A-6 and expiration date 10-25-19. A barcode and UPC 357664796832 are present.*

FDA Label Image

The Structural Formula For Olmesartan Medoxomil Is: (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 01)

Chemical structure of the active ingredient shown, Olmesartan Medoxomil, as part of the product Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide by DOH Central Pharmacy (NDC 53808-1120). The structure includes various rings and functional groups characteristic of this molecule.*

FDA Label Image

The Structural Formula For Amlodipine Besylate Is: (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 02)

Chemical structure diagram of the active ingredient Olmesartan Medoxomil, showing its molecular components along with an associated sulfonic acid group.*

FDA Label Image

The Structural Formula For Hydrochlorothiazide Is: (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 03)

Chemical structure of the active ingredient shown, Olmesartan Medoxomil, depicting its molecular arrangement with labeled functional groups including sulfonamide and chlorine substituents on a benzene ring.*

FDA Label Image

Figure 1: Mean Ambulatory Diastolic Blood Pressure At Endpoint By Treatment And Hour (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 04)

Line graph depicting mean ambulatory diastolic blood pressure (mmHg) over 24 hours post dose with multiple treatment groups labeled as Baseline, AM L10/HCT25, OM40/HCT25, OM40/AML10/HCT25. The x-axis represents hours post dose from 0 to 24, while the y-axis indicates diastolic BP ranging from 55 to 100 mmHg. The graph compares diastolic BP changes over time for each treatment.*

FDA Label Image

Figure 2: Mean Ambulatory Systolic Blood Pressure At Endpoint By Treatment And Hour (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 05)

Line graph depicting mean ambulatory systolic blood pressure (mmHg) over 24 hours post dose. The x-axis shows hours post dose from 0 to 24, and the y-axis shows blood pressure from 105 to 160 mmHg. Multiple treatment groups are plotted, including Baseline, AML10/HCTZ25, OM40/AML10, OM40/HCTZ25, and OM40/AML10/HCTZ25, illustrating their blood pressure trends across the day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.